A visionary innovator in biotechnology and bioengineering
We create develop biopharmaceuticals based on synthetic biology and systems-level genetic & genomic designs.
Our initial focus is to advance retroviral and lentiviral vector platforms. These serve as foundational technologies for CGT.
Our initial focus is to advance retroviral and lentiviral vector platforms. These serve as foundational technologies for CGT.
